Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wallace-Wilding, Kellie
NCT05930210: A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer	Recruiting	3	230	US, RoW	ENERGI-F703 GEL, ENERGI-F703 matched vehicle	Energenesis Biomedical Co., Ltd.	Diabetic Foot Ulcer, Foot Ulcer, Diabetes Mellitus, Wound	09/25	12/25
ACHIEVE-1, NCT05971940: A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone	Active, not recruiting	3	520	Japan, US, RoW	Orforglipron, LY3502970, Placebo	Eli Lilly and Company	Type 2 Diabetes	04/25	04/25
COMPASS, NCT05246839: Informed Choice - Compass	Active, not recruiting	N/A	1851	US	Brief Video, Brief Video Plus	Exact Sciences Corporation, Mayo Clinic, University of Utah, American Cancer Society, Inc., F!ght Colorectal Cancer	Colorectal Cancer	07/25	07/25
Ditah, Fausta
NCT03789162: Blood and Stool Sample Collection in Subjects with a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast	Active, not recruiting	N/A	1500	Canada, US		Exact Sciences Corporation	Colorectal Cancer	04/25	04/25